FDG-PET/CT in the Postoperative Period: Utility, Expected Findings, Complications, and Pitfalls

Gunjan Garg, Mohammed Taoudi Benchekroun, Tony Abraham

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

FDG-PET/CT as a modality is increasingly used for detection of recurrence and for restaging in patients with clinical suspicion of malignancy, as well as in patients with elevated tumor markers. However, there are many pitfalls in the interpretation of these scans when the studies are performed after some treatment. Some of these are attributed to normal physiological distribution and are compounded when there are inflammatory changes occurring after surgery. The body's inherent response to the surgical insult results in this inflammation. In addition, there are also complications that can happen following surgery, causing increased FDG uptake. Despite various fallacies, FDG-PET/CT provides valuable information in evaluation of residual and recurrent malignant disease. In this article, we aim to describe some of these postsurgical changes secondary to inflammation, common surgical complications, and finally, the utility of FDG-PET/CT in these patients to detect recurrent disease, even in the background of postsurgical changes.

Original languageEnglish (US)
JournalSeminars in Nuclear Medicine
DOIs
StateAccepted/In press - 2017

Fingerprint

Postoperative Period
Inflammation
Normal Distribution
Tumor Biomarkers
Recurrence
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

FDG-PET/CT in the Postoperative Period : Utility, Expected Findings, Complications, and Pitfalls. / Garg, Gunjan; Benchekroun, Mohammed Taoudi; Abraham, Tony.

In: Seminars in Nuclear Medicine, 2017.

Research output: Contribution to journalArticle

@article{9d36fc9357484dc3b7c257059c5eddce,
title = "FDG-PET/CT in the Postoperative Period: Utility, Expected Findings, Complications, and Pitfalls",
abstract = "FDG-PET/CT as a modality is increasingly used for detection of recurrence and for restaging in patients with clinical suspicion of malignancy, as well as in patients with elevated tumor markers. However, there are many pitfalls in the interpretation of these scans when the studies are performed after some treatment. Some of these are attributed to normal physiological distribution and are compounded when there are inflammatory changes occurring after surgery. The body's inherent response to the surgical insult results in this inflammation. In addition, there are also complications that can happen following surgery, causing increased FDG uptake. Despite various fallacies, FDG-PET/CT provides valuable information in evaluation of residual and recurrent malignant disease. In this article, we aim to describe some of these postsurgical changes secondary to inflammation, common surgical complications, and finally, the utility of FDG-PET/CT in these patients to detect recurrent disease, even in the background of postsurgical changes.",
author = "Gunjan Garg and Benchekroun, {Mohammed Taoudi} and Tony Abraham",
year = "2017",
doi = "10.1053/j.semnuclmed.2017.07.005",
language = "English (US)",
journal = "Seminars in Nuclear Medicine",
issn = "0001-2998",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - FDG-PET/CT in the Postoperative Period

T2 - Utility, Expected Findings, Complications, and Pitfalls

AU - Garg, Gunjan

AU - Benchekroun, Mohammed Taoudi

AU - Abraham, Tony

PY - 2017

Y1 - 2017

N2 - FDG-PET/CT as a modality is increasingly used for detection of recurrence and for restaging in patients with clinical suspicion of malignancy, as well as in patients with elevated tumor markers. However, there are many pitfalls in the interpretation of these scans when the studies are performed after some treatment. Some of these are attributed to normal physiological distribution and are compounded when there are inflammatory changes occurring after surgery. The body's inherent response to the surgical insult results in this inflammation. In addition, there are also complications that can happen following surgery, causing increased FDG uptake. Despite various fallacies, FDG-PET/CT provides valuable information in evaluation of residual and recurrent malignant disease. In this article, we aim to describe some of these postsurgical changes secondary to inflammation, common surgical complications, and finally, the utility of FDG-PET/CT in these patients to detect recurrent disease, even in the background of postsurgical changes.

AB - FDG-PET/CT as a modality is increasingly used for detection of recurrence and for restaging in patients with clinical suspicion of malignancy, as well as in patients with elevated tumor markers. However, there are many pitfalls in the interpretation of these scans when the studies are performed after some treatment. Some of these are attributed to normal physiological distribution and are compounded when there are inflammatory changes occurring after surgery. The body's inherent response to the surgical insult results in this inflammation. In addition, there are also complications that can happen following surgery, causing increased FDG uptake. Despite various fallacies, FDG-PET/CT provides valuable information in evaluation of residual and recurrent malignant disease. In this article, we aim to describe some of these postsurgical changes secondary to inflammation, common surgical complications, and finally, the utility of FDG-PET/CT in these patients to detect recurrent disease, even in the background of postsurgical changes.

UR - http://www.scopus.com/inward/record.url?scp=85025475614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025475614&partnerID=8YFLogxK

U2 - 10.1053/j.semnuclmed.2017.07.005

DO - 10.1053/j.semnuclmed.2017.07.005

M3 - Article

C2 - 28969758

AN - SCOPUS:85025475614

JO - Seminars in Nuclear Medicine

JF - Seminars in Nuclear Medicine

SN - 0001-2998

ER -